Ascyrus Medical

About

Acquired by Cryolife (now Artivion) in 2020, Ascyrus developed the world’s first medical device (the AMDS) designed specifically to address the unique challenges of acute type A aortic dissection, specifically DeBakey Type I. The design of the AMDS allows for rapid deployment of the graft in the aortic arch during a standard replacement of the ascending aorta, adding < 5 minutes to the procedure time. Deployment of the AMDS preserves the native arch, potentially allowing for the minimally invasive reinterventions, including the repair of additional entry tears, rather than an invasive arch repair. Studies have shown that the AMDS dramatically improves mortality and morbidity outcomes for patients with Type A/DeBakey 1 aortic dissections.